Ashok Mendhale

Department of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences, Maharashtra, India

Publications

  • Review Article   
    USE OF IVERMECTIN IN COVID-19
    Author(s): Ankita Jadhao*, Pramita Muntode and Ashok Mendhale

    The emergence of Coronavirus infection has produced a concerning scenario all across the world. COVID-19 is made up of a single stranded positive sense RNA gene that is wrapped in a crown shaped collection of spike glycoproteins in an external membrane. Depending on the person's genetics, race, age and geographic region, COVID-19 infection can cause a range of symptoms and morbidity. Pulmonary epithelial cell death, thrombosis, hyper coagulation and vascular leak are all part of COVID-19 pathophysiology, which can lead to sepsis in severe instances. As a result of these events, Acute Respiratory Distress Syndrome (ARDS) and lung fibrosis occur. The vital to create a therapeutic approach is to stop COVID-19 from spreading. COVID-19 instances are on the rise every day, yet there is no effective therapy or vaccine available. Several clinical studies are being done in.. Read More»

    Abstract HTML PDF